Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

RSS icon

Study: Life purpose may protect against neuro changes associated with Alzheimer's

Higher levels of purpose in life reduce the deleterious effects of Alzheimers disease pathologic changes on cognition in advanced age, according to a longitudinal, epidemiologic and clinicopathologic study in the May issue of the Archives of General Psychiatry.

CMS extends Sunshine Act

The Centers for Medicare & Medicaid Services (CMS) has amended the Physician Payments Sunshine Act to provide time for organizations to prepare for data submission.

ASBrS: Time to pull the plug on thermography for breast screening?

Infrared thermography is not a reliable breast cancer screening tool, according to a study presented at the American Society of Breast Surgeons (ASBrS) annual meeting in Phoenix, May 2-6.

Philips, Phoenix hospital ink deal for MR neuro research

Royal Philips Electronics has established a five-year agreement with St. Josephs Hospital and Medical Center in Phoenix to pursue neurology research with MRI technology.

Banner Health nets HIMSS Stage 7 status

Banner Health, headquartered in Phoenix, has received HIMSS Analytics' Stage 7 Award for 17 of its 23 hospitals, located in seven U.S. states: Alaska, Arizona, California, Colorado, Nebraska, Nevada and Wyoming. The Stage 7 award represents attainment of the highest level on the EMR Adoption Model (EMRAM), which is used to track EMR progress at hospitals and health systems.

Study: Breast brachytherapy may be best for local tumor control

Accelerated partial breast irradiation is more effective in preventing local breast cancer recurrence than whole breast irradiation, according to a study presented at the American Society of Breast Surgeons (ASBrS) annual meeting in Phoenix, May 2-6.

JNM: SPECT/CT elevates interpretation of radioiodine scintigraphy

Source: J Nuc Med 2012;53:754-64SPECT/CT is a powerful diagnostic tool that has improved interpretation of classic radioiodine scintigraphy, and current management protocols and guidelines in thyroid cancer should be reassessed in light of this new technology, according to an article published in the May issue of the Journal of Nuclear Medicine.

FDA ups its vigilance on clinical investigators

Starting May 30, the FDA will keep a more watchful eye on disqualified clinical investigators. Now, a clinical site investigator deemed ineligible to receive a certain test article (drugs, devices or new animal drugs) will also be ineligible to conduct any clinical investigations that would support an application for research or marketing permit for other products that are FDA regulated.

Displaying 6817 - 6824 of 23641

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.